AstraZeneca faces just one generic version of its blockbuster statin med Crestor. And the U.K. drug giant wants to keep it that way. The company has filed a citizen petition with the FDA contending that the agency can’t approve more generics because it granted Crestor a new indication in late May--one that likely comes with a pediatric orphan drug exclusivity that would last till May 2023. The petition sets out a series of legal reasons why the FDA can’t “carve out” that exclusive indica...
As Crestor generics gear up to battle the brand, AstraZeneca is retrenching with a $1.5 billion restructuring plan.
AstraZeneca said on Thursday its blockbuster cholesterol medicine Crestor faced a generic... 4 cents in a Reuters poll of 18 analysts, reflecting competition from cheap generics plus...
"We should prioritize the use of 'statin single agent' as the initial treatment option, as recommended by the guidelines. In Korea, there is a growing trend to prescribe 'combination drugs’, which pose financial issues and may lead to a negative perception of statin drugs among patients in the future." · Since its introduction in Korea in 2004, Crestor, often referred to as a'super statin', has been the only statin approved for slowing the progression of atherosclerosis in patients with hypercholesterolemia. It is also indic ...
Lipitor and Crestor are both brand-name drugs. These drugs also both have generic forms. You’ll usually pay more for brand-name drugs than for generics. If you’re interested in using...
Crestor is a brand-name prescription drug. It’s FDA-approved to: ; manage lipid* levels for high cholesterol and mixed hyperlipidemia ; lower cholesterol levels for an inherited type of high cholesterol known as heterozygous familial hypercholesterolemia (HeFH) ; lower cholesterol levels for an inherited kind of high cholesterol called homozygous familial hypercholesterolemia (HoFH) ; treat high triglyceride levels
of generics by rival companies after patent expiration. This... cheaper generics, and market observers project the trend to... Generally, the manufacture of generics or copies of a drug and...
Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca Share full article Enjoy unlimited access to all of The Times. See subscription options
Now that it appears that Crestor is not superior enough to Lipitor, it may not be prescribed over the generics and Lipitor itself. AstraZeneca’s investors, however, should be careful not...
Neurogene hits a setback in the clinic, days after fundraise · Nov. 12, 2024 ; Moderna earnings beat forecasts, but analysts question whether sales spike will last · Nov. 7, 2024 ; With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC · Nov. 7, 2024